Valuation Alterity Therapeutics Limited Nasdaq

Stocks

Market Closed - Nasdaq 00:30:00 17/09/2026 +04			5-day change	1st Jan Change
3.850 ^USD	+10.00%		-14.44%	+25.00%

08-31	Alterity Therapeutics Enters Underwriting Agreement for Exercise of up to 8.4 Million Listed Options	MT
08-28	Alterity Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	21.56	11.37	14	59.84	86.52	67.69	-	-
Change	-	-47.27%	23.14%	327.48%	44.59%	-21.77%	-	-
Enterprise Value (EV) ¹	21.56	11.37	9.172	38.2	59.75	26.79	30.54	61.88
Change	-	-47.27%	-19.31%	316.5%	56.4%	-55.16%	14%	102.62%
P/E	-	-	-	-	-5.17x	-3.15x	-0.39x	-5.38x
PBR	-	-	-	-	-	-	-	-
PEG	-	-	-	-	-	-0.1x	-0x	0.1x
Capitalization / Revenue	6.11x	4.45x	4.81x	11.3x	22.6x	142x	34.2x	27.6x
EV / Revenue	6.11x	4.45x	3.15x	7.24x	15.6x	56.3x	15.4x	25.2x
EV / EBITDA	-	-	-0.71x	-4.68x	-3.59x	-1.18x	-1.31x	-3.05x
EV / EBIT	-2.07x	-1.22x	-0.71x	-4.87x	-3.59x	-0.99x	-0.99x	-1.9x
EV / FCF	-2.53x	-	-1.07x	-5.11x	-3.7x	-1.23x	-1.42x	-3.37x
FCF Yield	-39.6%	-	-93.4%	-19.6%	-27%	-81.5%	-70.3%	-29.7%
Dividend per Share ³	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ³	-	-	-	-	-0.1112	-0.1367	-1.1	-0.08
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3.528	2.554	2.909	5.278	3.832	0.4754	1.978	2.451
EBITDA ¹	-	-	-12.95	-8.155	-16.62	-22.78	-23.3	-20.3
EBIT ¹	-10.42	-9.321	-12.97	-7.839	-16.63	-27.12	-30.98	-32.57
Net income ¹	-8.843	-8.966	-12.97	-7.927	-16.83	-27.54	-30.84	-31.61
Net Debt ¹	-	-	-4.826	-21.64	-26.77	-40.9	-37.15	-5.813
Reference price ³	0.6500	0.3500	0.2000	0.5000	0.5750	0.4300	0.4300	0.4300
Nbr of stocks (in thousands)	48,137	48,798	104,902	182,547	217,509	220,701	-	-
Announcement Date	31/08/22	31/08/23	29/08/24	28/08/25	28/08/26	-	-	-

¹AUD in Million²USD in Million³AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	31.39x	5.65x	16.94x	1.03%	45.81B
REVOLUTION MEDICINES, INC.	-20.96x	242.19x	-22.49x	-.--%	43.91B
IQVIA HOLDINGS INC.	34.73x	3.34x	14.43x	-.--%	44.39B
BEONE MEDICINES AG	45.39x	5.23x	28.64x	-.--%	39.4B
CELLTRION, INC.	26.93x	8.12x	20.58x	0.42%	31.26B
MEDPACE HOLDINGS, INC.	35.28x	5.79x	26.31x	-.--%	17.32B
EUROFINS SCIENTIFIC SE	24.5x	2.13x	9.21x	1.09%	14.73B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	73x	3.87x	15.01x	-.--%	13.03B
Average	31.28x	34.54x	13.58x	0.32%	31.23B
Weighted average by Cap.	26.47x	46.77x	11.96x	0.31%